The issue as to whether the new, so-called “right-to-try” legislation is a good idea or not is contentious and your sitemaster has no interest in getting into that discussion. What is a fact is that it has now been signed into law. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: "right to try", access, bill, drug, investigational, law | 2 Comments »
As regular readers may remember, The “New” Prostate Cancer InfoLink has been keeping an eye on the court case known as the Association for Molecular Pathology v. Myriad Genetics, Inc. The case relates to the rights of the biotechnology industry (or indeed any other organization or individual) to hold patents on human genes and/or their scientific uses. … READ MORE …
Filed under: Uncategorized | Tagged: gene, law, Myriad Genetics, patent | 2 Comments »
There are two ways to look at a ruling issued yesterday by the Indian controller general of patents, designs and trademarks: it can either be seen as a major victory for patients who had no prior hope of treatment with a highly effective anticancer agent because of its cost … or it can be seen as an international setback to the entire concept of patent and intellectual property law. … READ MORE …
Filed under: Drugs in development | Tagged: development, drug, innovation, law, patent | 7 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 